GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (MEX:OPK) » Definitions » Other Operating Expense

OPKO Health (MEX:OPK) Other Operating Expense : MXN1,607 Mil (TTM As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is OPKO Health Other Operating Expense?

OPKO Health's Other Operating Expense for the three months ended in Mar. 2025 was MXN406 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was MXN1,607 Mil.

OPKO Health's quarterly Other Operating Expense increased from Sep. 2024 (MXN402 Mil) to Dec. 2024 (MXN424 Mil) but then declined from Dec. 2024 (MXN424 Mil) to Mar. 2025 (MXN406 Mil).

OPKO Health's annual Other Operating Expense declined from Dec. 2022 (MXN1,711 Mil) to Dec. 2023 (MXN1,460 Mil) but then increased from Dec. 2023 (MXN1,460 Mil) to Dec. 2024 (MXN1,723 Mil).


OPKO Health Other Operating Expense Historical Data

The historical data trend for OPKO Health's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Other Operating Expense Chart

OPKO Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,121.73 1,031.40 1,711.44 1,460.33 1,723.39

OPKO Health Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 355.78 374.10 402.33 424.29 406.32

OPKO Health Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN1,607 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OPKO Health Other Operating Expense Related Terms

Thank you for viewing the detailed overview of OPKO Health's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


OPKO Health Business Description

Traded in Other Exchanges
Address
4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.